Early Detection of Cancer
"Early Detection of Cancer" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Methods to identify and characterize cancer in the early stages of disease and predict tumor behavior.
| Descriptor ID |
D055088
|
| MeSH Number(s) |
E01.390.500
|
| Concept/Terms |
Cancer Screening Tests- Cancer Screening Tests
- Cancer Screening Test
- Screening Test, Cancer
- Screening Tests, Cancer
- Test, Cancer Screening
- Tests, Cancer Screening
|
Below are MeSH descriptors whose meaning is more general than "Early Detection of Cancer".
Below are MeSH descriptors whose meaning is more specific than "Early Detection of Cancer".
This graph shows the total number of publications written about "Early Detection of Cancer" by people in this website by year, and whether "Early Detection of Cancer" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2008 | 0 | 2 | 2 |
| 2009 | 0 | 2 | 2 |
| 2010 | 4 | 3 | 7 |
| 2011 | 5 | 5 | 10 |
| 2012 | 9 | 4 | 13 |
| 2013 | 5 | 8 | 13 |
| 2014 | 21 | 7 | 28 |
| 2015 | 15 | 11 | 26 |
| 2016 | 13 | 12 | 25 |
| 2017 | 15 | 13 | 28 |
| 2018 | 24 | 14 | 38 |
| 2019 | 16 | 14 | 30 |
| 2020 | 16 | 16 | 32 |
| 2021 | 14 | 23 | 37 |
| 2022 | 7 | 25 | 32 |
| 2023 | 7 | 25 | 32 |
| 2024 | 24 | 7 | 31 |
| 2025 | 27 | 5 | 32 |
| 2026 | 14 | 6 | 20 |
To return to the timeline,
click here.
Below are the most recent publications written about "Early Detection of Cancer" by people in Profiles.
-
Development of a clinical prediction model using volatile organic compounds as breath biomarkers in squamous oesophageal neoplasms: ViSON, protocol for a multicentre case-control study in UK NHS hospitals. BMJ Open. 2026 Sep 28; 16(9):e112493.
-
Early detection of invasive lung cancer and multiorgan metastasis by a collagen-targeted protein MRI contrast agent. Sci Adv. 2026 Sep 11; 12(37):eadz6815.
-
The American Cancer Society National Lung Cancer Roundtable strategic plan: Opportunities in advanced imaging across the lung cancer care continuum. Cancer. 2026 Aug 15; 132(16):e70516.
-
Prostate Cancer Mortality After Relabeling Low-Grade Prostate Cancer as Precancerous. JAMA Oncol. 2026 07 01; 12(7):767-771.
-
Stockholm3-Magnetic Resonance Imaging Population-Based Prostate Cancer Screening Study: Two-Year Follow-up. Ann Intern Med. 2026 Jul; 179(7):988-995.
-
Methylation plus alpha-fetoprotein blood test for early detection of HCC in at-risk populations. Hepatol Commun. 2026 Jul 01; 10(7).
-
Living evidence-informed guideline on the early detection of oral squamous cell carcinoma and potentially malignant disorders: Light-based adjuncts to determine the need for biopsy, Version 2026 1.0. J Am Dent Assoc. 2026 Sep; 157(9):968-979.
-
Light-based adjuncts to determine the need for biopsy for early detection of oral squamous cell carcinoma and potentially malignant disorders: An evidence summary of a living systematic review, Version 2026 1.0. J Am Dent Assoc. 2026 Sep; 157(9):980-992.
-
BMI and Initiation of Cancer Screening: A Closer Look at Differences by Race, Ethnicity, and Sex in a Multicenter Population. Am J Prev Med. 2026 Oct; 71(4):108434.
-
Anal Cancer Screening Prevalence in U.S. Cities and Factors Associated With Screening. Am J Prev Med. 2026 Sep; 71(3):108373.